Karen Herrera-Ferrá1,2, Humberto Nicolini1,3, James Giordano2,4. 1. Asociación Mexicana de Neuroética, Atizapán, State of Mexico, Mexico. 2. Neuroethics Studies Program, Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC, USA. 3. Lab. de Enfermedades Psiquiátricas, Neurodegenerativas y Adicciones, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico. 4. Departments of Neurology and Biochemistry, Georgetown University Medical Center, Washington, DC, USA.